Identification of a Novel Mutation in a Family with Pseudohypoparathyroidism Type 1a
Adelaide Moutinho1, Rosa Carvalho2, Rita Ferreira Reis3
1Department of Internal Medicine, Hospital de Chaves, Centro Hospitalar de Trás-os-Montes e Alto Douro, Chaves, Portugal.
Introduction:
Pseudohypoparathyroidism type 1a is caused by GNAS mutations leading to target organ resistance to multiple hormones rather than parathyroid hormone, resulting not only in hypocalcemia, but also in Albright's hereditary osteodystrophy phenotype.
Materials And Methods:
DNA sequencing of the GNAS gene identified a novel heterozygous mutation in peripheral blood leukocytes in the family presented in this case report.
Results:
We present a case of a 25-year-old woman with pseudohypoparathyroidism type 1a admitted with seizures, whose family presents an autosomal dominant transmission of a novel heterozygous GNAS mutation (c.524_530+3del).
Conclusion:
Pseudohypoparathyroidism type 1a is mostly caused by inactivating GNAS mutations that have been gradually reported in the literature that lead to a typical and complex clinical phenotype and resistance to multiple hormones. The deletion caused by the mutation identified in the presented case has not been reported previously.
Insights
Pseudohypoparathyroidism type 1a, a genetic disorder, involves GNAS mutations causing hormone resistance and Albright's hereditary osteodystrophy. A novel GNAS mutation was identified in a family with this condition.
Area of Science:
- Genetics
- Endocrinology
Background:
- Pseudohypoparathyroidism type 1a (PHP1a) is characterized by GNAS gene mutations.
- These mutations lead to resistance in multiple hormone target organs, not just parathyroid hormone.
- PHP1a manifests with hypocalcemia and Albright's hereditary osteodystrophy phenotype.
Observation:
- A case report details a 25-year-old woman with PHP1a presenting with seizures.
- Her family exhibits autosomal dominant transmission of a GNAS mutation.
- DNA sequencing revealed a novel heterozygous GNAS mutation (c.524_530+3del) in peripheral blood leukocytes.
Findings:
- A novel heterozygous GNAS mutation, c.524_530+3del, was identified.
- This specific deletion mutation has not been previously reported in the literature.
- The mutation contributes to the complex clinical phenotype of PHP1a.
Implications:
- This discovery expands the known spectrum of GNAS mutations causing PHP1a.
- Understanding novel mutations aids in diagnosing and managing PHP1a.
- Further research into GNAS mutations can elucidate hormone resistance mechanisms.
More Related Videos
03:45Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
10:40Comprehensive Workflow for the Genome-wide Identification and Expression Meta-analysis of the ATL E3 Ubiquitin Ligase Gene Family in Grapevine
Published on: December 22, 2017
Related Concept Videos
02:47Protein Families
02:47Protein Families
01:57Gene Families
Occasionally these regions can be adapted to take on new roles within the organism, becoming novel genes...
01:57Gene Families
01:39Mutations
01:35Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...